JAMA +AI Weekly Update October 25, 2025

We’re taking this opportunity to resurface our Special Communication, “AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial Intelligence.”

This Report, authored by over 50 experts in AI, defines current AI tools in health and health care, explains challenges for their regulation, evaluation, and responsible use, and concludes with potential solutions and implications for the health care workforce.

It is accompanied by a podcast, “AI, Health, and Health Care,” where JAMA Senior Editor Derek Angus, MD, MPH, joins JAMA+ AI Editor in Chief Roy Perlis, MD, MSc, to break down the Report’s key findings.

Read the report and listen to the podcast.

Editor’s Picks in this week’s JAMA+ AI:   

• Recalls of FDA-cleared AI-enabled medical devices were rare but occurred mostly soon after clearance and often involved products without clinical validation from publicly traded companies, suggesting the 510(k) process may miss early AI performance issues. (JAMA Health Forum)
• Among patients with hepatocellular carcinoma, a machine learning-based decision-support model estimated accurate risk stratification and identified the potential for improved survival and identification of liver transplant candidates. (JAMA Network Open)
• A self-guided digital intervention improved psychological distress and quality of life in patients with inflammatory rheumatic disease, suggesting it may be a promising, scalable approach to bridge the mental health access gap in rheumatology. (JAMA Network Open)